These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9658837)

  • 1. [New techniques in maxillofacial surgery: local injection treatment with botulinum toxin A].
    Roser M; Cornelius CP; Topka H
    Mund Kiefer Gesichtschir; 1998 May; 2 Suppl 1():S121-4. PubMed ID: 9658837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New applications in maxillofacial surgery: Local injections with botulinum toxin type A].
    Roser M; Cornelius CP; Topka H
    Mund Kiefer Gesichtschir; 1998 May; 2(Suppl 1):S121-4. PubMed ID: 23525990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.
    Mendes RA; Upton LG
    Br J Oral Maxillofac Surg; 2009 Sep; 47(6):481-3. PubMed ID: 18829144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperfunctional lines of the face with botulinum toxin A.
    Binder WJ; Blitzer A; Brin MF
    Dermatol Surg; 1998 Nov; 24(11):1198-205. PubMed ID: 9834739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A injection in the treatment of hemifacial spasm.
    Chen RS; Lu CS; Tsai CH
    Acta Neurol Scand; 1996 Sep; 94(3):207-11. PubMed ID: 8899054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect.
    Durand PD; Couto RA; Isakov R; Yoo DB; Azizzadeh B; Guyuron B; Zins JE
    Aesthet Surg J; 2016 Apr; 36(4):482-7. PubMed ID: 26780946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin in clinical practice.
    Hughes AJ
    Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action, clinical indication and results of treatment of botulinum toxin].
    Lagueny A; Burbaud P
    Neurophysiol Clin; 1996; 26(4):216-26. PubMed ID: 8975111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin injections under electromyographic guidance].
    Bogucki A
    Neurol Neurochir Pol; 1998; 32 Suppl 1():85-93. PubMed ID: 9608557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin.
    Sedano MJ; Trejo JM; Macarrón JL; Polo JM; Berciano J; Calleja J
    Eur Neurol; 2000; 43(3):137-40. PubMed ID: 10765052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
    Sheen-Ophir S; Almog Y
    Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J; Schwab J; Hubert C; Abbott CC
    Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.